LENTIGLOBIN
LIVE

Serial Number

79228010

Owner

Bluebird Bio (UK) Ltd.

Attorney

John L. DuPre'

Filing Date

Jun 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LENTIGLOBIN Trademark

Serial Number: 79228010 • Registration: 5736038

LENTIGLOBIN is a trademark filed by Bluebird Bio (UK) Ltd. on June 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bluebird Bio (UK) Ltd. (46 trademarks)

Belvedere House,

Entity Type: 99

bluebird bio, Inc. (77 trademarks)

455 Grand Union Blvd

Entity Type: 03

Genetix Biotherapeutics Inc. (63 trademarks)

455 Grand Union Boulevard
Somerville, MA 02145

Entity Type: 03

Trademark Details

Filing Date

June 30, 2017

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

November 14, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of genetic diseases

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2025 ADCH
CANCELLED SECTION 71
Nov 14, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 25, 2025 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 13, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 15, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2024 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 23, 2023 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 23, 2023 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 26, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 24, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 24, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2019 TCCA
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 9, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 20, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2018 CRFA
ASSIGNED TO LIE
Dec 7, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 4, 2018 ERSI
CHANGE OF OWNER RECEIVED FROM IB
Nov 8, 2018 CHLD
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2018 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2018 TROA
REFUSAL PROCESSED BY IB
Apr 6, 2018 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2018 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 10, 2018 MAFR
ASSIGNED TO EXAMINER
Mar 6, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2018 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 1, 2018 SDRC